BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10756189)

  • 1. Site-specific modification and RNA crosslinking of the RNA-binding domain of PKR.
    Spanggord RJ; Beal PA
    Nucleic Acids Res; 2000 May; 28(9):1899-905. PubMed ID: 10756189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective binding by the RNA binding domain of PKR revealed by affinity cleavage.
    Spanggord RJ; Beal PA
    Biochemistry; 2001 Apr; 40(14):4272-80. PubMed ID: 11284683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia.
    Murad JM; Tone LG; de Souza LR; De Lucca FL
    Blood Cells Mol Dis; 2005; 34(1):1-5. PubMed ID: 15607693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. trans-Autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR.
    Wu S; Kaufman RJ
    Biochemistry; 2004 Aug; 43(34):11027-34. PubMed ID: 15323561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity.
    Jammi NV; Beal PA
    Nucleic Acids Res; 2001 Jul; 29(14):3020-9. PubMed ID: 11452027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical analysis of PKR activation by PACT.
    Peters GA; Dickerman B; Sen GC
    Biochemistry; 2009 Aug; 48(31):7441-7. PubMed ID: 19580324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of binding sites for both dsRBMs of PKR on kinase-activating and kinase-inhibiting RNA ligands.
    Spanggord RJ; Vuyisich M; Beal PA
    Biochemistry; 2002 Apr; 41(14):4511-20. PubMed ID: 11926812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic characterization of the 5'-triphosphate-dependent activation of PKR: lack of 5'-end nucleobase specificity, evidence for a distinct triphosphate binding site, and a critical role for the dsRBD.
    Toroney R; Hull CM; Sokoloski JE; Bevilacqua PC
    RNA; 2012 Oct; 18(10):1862-74. PubMed ID: 22912486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variola virus E3L Zα domain, but not its Z-DNA binding activity, is required for PKR inhibition.
    Thakur M; Seo EJ; Dever TE
    RNA; 2014 Feb; 20(2):214-27. PubMed ID: 24335187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2.
    Romano PR; Garcia-Barrio MT; Zhang X; Wang Q; Taylor DR; Zhang F; Herring C; Mathews MB; Qin J; Hinnebusch AG
    Mol Cell Biol; 1998 Apr; 18(4):2282-97. PubMed ID: 9528799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation.
    Barber GN; Wambach M; Thompson S; Jagus R; Katze MG
    Mol Cell Biol; 1995 Jun; 15(6):3138-46. PubMed ID: 7539103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new double-stranded RNA-binding protein that interacts with PKR.
    Coolidge CJ; Patton JG
    Nucleic Acids Res; 2000 Mar; 28(6):1407-17. PubMed ID: 10684936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain.
    Cassady KA; Gross M
    J Virol; 2002 Mar; 76(5):2029-35. PubMed ID: 11836380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR.
    Dorin D; Bonnet MC; Bannwarth S; Gatignol A; Meurs EF; Vaquero C
    J Biol Chem; 2003 Feb; 278(7):4440-8. PubMed ID: 12475984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchestration of the activation of protein kinase R by the RNA-binding motif.
    Sadler AJ
    J Interferon Cytokine Res; 2010 Apr; 30(4):195-204. PubMed ID: 20377414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase.
    Parker LM; Fierro-Monti I; Mathews MB
    J Biol Chem; 2001 Aug; 276(35):32522-30. PubMed ID: 11438540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus.
    Vuyisich M; Spanggord RJ; Beal PA
    EMBO Rep; 2002 Jul; 3(7):622-7. PubMed ID: 12101093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR.
    Tian B; Mathews MB
    J Biol Chem; 2001 Mar; 276(13):9936-44. PubMed ID: 11134010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR.
    Fasciano S; Hutchins B; Handy I; Patel RC
    FEBS J; 2005 Mar; 272(6):1425-39. PubMed ID: 15752359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for PKR activation by PACT or dsRNA.
    Li S; Peters GA; Ding K; Zhang X; Qin J; Sen GC
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):10005-10. PubMed ID: 16785445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.